ID physician. Interested in Antimicrobial & Diagnostic Stewardship | Healthcare Epidemiology | Infection Control. Retweet≠endorsement

Denver, CO
Joined May 2013
Thrilled to share my K12 Aim 1 in OFID! 25 nursing home stakeholders on penicillin allergy delabeling: 1. Labels go unquestioned, 2. Labels doubted, rarely removed, 3. Structural barriers decide, 4. Feasibility varies by facility, 5. Trust can't be assumed academic.oup.com/ofid/articl…
2
63
🚨🔥 Hot off the press in JAMA Network Open! Our qualitative study on penicillin allergy delabeling in primary care setting. We interviewed 119 patients and clinicians across three Boston networks to find out why delabeling so rarely happens. jamanetwork.com/journals/jam…
153
Using Wisconsin DOC data, we found 9% of incarcerated individuals had penicillin allergy labels, and those with these labels were more likely to receive antibiotics overall, including agents with a high risk for C. diff infection. shorturl.at/jRzXf
152
Kap Sum Foong, MD FIDSA retweeted
Penicillin Allergy Labels and High-Risk Antibiotic Prescribing Among Incarcerated Individuals Receiving Antibiotics Across Four U.S. Carceral Systems ✅ Just Accepted 🔗 bit.ly/4bjud6Q
1
7
741
Our new publication: In four US correctional systems, 10% of incarcerated individuals receiving antibiotics carried a penicillin allergy label, and those labels were associated with >2× odds of high-risk C. difficile–associated antibiotic use. Read more: doi.org/10.1093/ofid/ofag128
1
1
125
Kap Sum Foong, MD FIDSA retweeted
A Public Health Approach to Antimicrobial Stewardship in Long-Term Care Facilities: A Multifaceted Program in Massachusetts ✅ Just Accepted 🔗 bit.ly/4aOMhFJ
1
3
701
🚨 Excited to share our new publication in CID! Antimicrobial stewardship in LTC is feasible and scalable when supported by public health infrastructure. A multicomponent approach can shift prescribing toward safer patterns. doi.org/10.1093/cid/ciag092
1
1
501
Grateful to IDSA for the opportunity to contribute to Science Speaks blog. This piece reflects on implementation challenges and emerging policy opportunities, and what it will take to make penicillin allergy delabeling more accessible, equitable, and scalable.
157
Great time at #IDWeek2025! 1️⃣ Reconnecting with friends 2️⃣ Honored to be inducted as a FIDSA alongside one of my favorite WashU seniors 3️⃣ Grateful to present our collaborative work with Massachusetts DPH on the statewide Antibiotic Start Reporting Program in long-term care
211
Thrilled to share our new publication on #penicillinallergy #delabeling practices and barries across SHEA SRN institutions. We found wide variability in practices, with barriers eg limited EHR integration, and lack of outcome tracking. doi.org/10.1017/ice.2025.103…
3
439
Excited to share our Letter to the Editor urging caution on adopting plasma #mNGS for #NHSN #CLABSI surveillance, highlighting why it may not be ready for prime time. Grateful to my co-authors for their insights. cambridge.org/core/journals/…
1
166
Happy to have contributed to the Clinical Dilemmas in Infectious Diseases series in CID. Grateful for the opportunity to share this challenging case and the lessons it offers for clinical practice. academic.oup.com/cid/advance…
1
2
224
Honored to be elected a Fellow of the Infectious Diseases Society of America (FIDSA) this year! Grateful for the support and nomination from Drs. Deb Poutsiaka and Shira Doron. #IDSA idsociety.org/news--publicat…
5
164
Excited to share our commentary on #PenicillinAllergy delabeling in long-term care facilities—if not now, then when? We explore gaps, barriers, and actionable solutions for #Delabeling in this vulnerable population! #Geriatrics doi.org/10.1017/ash.2025.30 @ShiraDoronMD @IDDoc1978
1
3
430
Excited to share our new publication! Our findings show incomplete beta-lactam #allergy documentation increases the risk of prescribing antibiotics most associated with #Cdiff infection in long-term care residents.#delabeling @ShiraDoronMD @IDDoc1978 doi.org/10.1093/ajhp/zxae412
1
4
1,118